Hong Kong will carry out city-wide compulsory nucleic acid testing for COVID-19. Two enterprises in Beijing's Daxing district are helping the special administrative region carry out the tests. 

Staff members of Juxiechang (Beijing) Pharmaceutical Co attend a TCM medicine donation ceremony for Hong Kong institutions. [Photo provided by Daxing district]

Juxiechang (Beijing) Pharmaceutical Co has donated 200,000 boxes of Jinhua Qinggan Granules -- one of three TCM medicines that have been proven effective in treating COVID-19 patients -- to major charities, trade unions, media and medical colleges in Hong Kong.

The medicine is expected to reduce the pressure resulting from a shortage of medical resources, as it has been included in the fourth, fifth, sixth, seventh and eighth treatment guidelines provided by the National Health Commission.

COVID-19 antigen detection kits offered by Beijing Hotgen Biotech Co are transported to Hong Kong. [Photo provided by Daxing district]

Beijing Hotgen Biotech Co, a high-tech enterprise focusing on the research & development, manufacture and sales of medical and public safety inspection products, sent over 50 million COVID-19 antigen detection kits to Hong Kong on Feb 11 for home monitoring.

This product has obtained the German BfArM certification, European Union CE certification, and clinical verification of Brazil and the UK supported by the Global Foundation for Innovative Diagnostics. It is now on the market in many countries, including Germany, the UK, France and Italy.